Argyris Spyrou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Argyris Spyrou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Niclas Roxhed
Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden
2 shared publications - Theocharis Nikiforos Iordanidis
Division of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden
2 shared publications Göran Stemme
Department of Micro and Nanosystems, School of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm 100 44, Sweden
1 shared publication- Göran Stemme
Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden
1 shared publication - Xu Tian
KTH Royal Institute of Technology
1 shared publication
Latest Publications
- Open Access
MEMS-Based Ultrasonic Energy Harvesting Platform Enabling Sustained In Vivo Operation of Implantable Microdevices
Implantable microdevices capable of autonomous operation over extended lifetimes are promising enablers for minimally invasive diagnostics and therapy. Microelectromechanical systems (MEMS)-based piezoelectric ultrasonic energy harvesters (PUEH) have emerged as a compelling approach for powering implantable microdevices, where both miniaturization and efficient wireless energy transfer are essential. Here, we present a highly miniaturized (5 × 5 × 5 mm³) ultrasonic energy-harvesting platform enabling sustained in vivo operation of implantable microdevices. The platform integrates a MEMS-PUEH, a high-efficiency power management system, an energy storage element, and representative functional electronics. We first investigate the effect of backside cavity boundary conditions on MEMS-PUEH performance and show that a sealed air-filled chamber significantly outperforms an open water-filled cavity, yielding a 46% increase in root-mean-square output voltage and a 117% increase in average output power across a 2 kΩ resistive load under identical incident acoustic intensity at the respective optimal operating frequencies. We then demonstrate system-level integration and characterization. In a tissue-mimicking phantom, under an incident acoustic intensity of approximately 257 mW/cm 2 , the device charges an 11.5 mF supercapacitor, a 5 µAh solid-state microbattery, and a 100 µF capacitor to their nominal voltages in less than 5 min, 3 min, and 20 s, respectively. Finally, in vivo validation demonstrates fully autonomous operation of representative functional electronics following ultrasonic charging of the onboard energy storage element. These results establish a highly miniaturized and fully integrated ultrasonic energy-harvesting platform that advances MEMS-based power solutions for implantable biomedical microdevices.
Open AccessMEMS-Based Ultrasonic Energy Harvesting Platform Enabling Sustained In Vivo Operation of Implantable Microdevices
Implantable microdevices capable of autonomous operation over extended lifetimes are promising enablers for minimally invasive diagnostics and therapy. Microelectromechanical systems (MEMS)-based piezoelectric ultrasonic energy harvesters (PUEH) have emerged as a compelling approach for powering implantable microdevices, where both miniaturization and efficient wireless energy transfer are essential. Here, we present a highly miniaturized (5 × 5 × 5 mm³) ultrasonic energy-harvesting platform enabling sustained in vivo operation of implantable microdevices. The platform integrates a MEMS-PUEH, a high-efficiency power management system, an energy storage element, and representative functional electronics. We first investigate the effect of backside cavity boundary conditions on MEMS-PUEH performance and show that a sealed air-filled chamber significantly outperforms an open water-filled cavity, yielding a 46% increase in root-mean-square output voltage and a 117% increase in average output power across a 2 kΩ resistive load under identical incident acoustic intensity at the respective optimal operating frequencies. We then demonstrate system-level integration and characterization. In a tissue-mimicking phantom, under an incident acoustic intensity of approximately 257 mW/cm 2 , the device charges an 11.5 mF supercapacitor, a 5 µAh solid-state microbattery, and a 100 µF capacitor to their nominal voltages in less than 5 min, 3 min, and 20 s, respectively. Finally, in vivo validation demonstrates fully autonomous operation of representative functional electronics following ultrasonic charging of the onboard energy storage element. These results establish a highly miniaturized and fully integrated ultrasonic energy-harvesting platform that advances MEMS-based power solutions for implantable biomedical microdevices.
- Open Access
- 18 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 34 (5) , 691-700
Ultrasonic Selective Opening of Microcavities for Drug Delivery Microimplants
We present a fully passive, ultraminiaturized drug delivery microchip that enables wireless, on-demand release via ultrasonic actuation - a mechanism not previously demonstrated in implantable drug delivery systems. By eliminating the need for integrated power and control components, the device achieves sub-millimeter dimensions ( $\times 0.5$ mm $\times 1$ mm), enabling minimally invasive implantation in sensitive or hard-to-reach tissues. The system relies on ultrathin metallic membranes ( $\mu $ m wide, $2~\mu $ g of powder payload from individual microcavities in response to specific frequencies (360/420/580kHz), with membrane rupture occurring in in vivo conditions at ultrasonic intensities within clinically safe limits (2 ). This platform represents a significant step toward precise, programmable drug delivery in anatomically constrained or delicate regions.[2025-0104]
- 18 August 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 34 (5) , 691-700
Open AccessUltrasonic Selective Opening of Microcavities for Drug Delivery Microimplants
We present a fully passive, ultraminiaturized drug delivery microchip that enables wireless, on-demand release via ultrasonic actuation - a mechanism not previously demonstrated in implantable drug delivery systems. By eliminating the need for integrated power and control components, the device achieves sub-millimeter dimensions ( $\times 0.5$ mm $\times 1$ mm), enabling minimally invasive implantation in sensitive or hard-to-reach tissues. The system relies on ultrathin metallic membranes ( $\mu $ m wide, $2~\mu $ g of powder payload from individual microcavities in response to specific frequencies (360/420/580kHz), with membrane rupture occurring in in vivo conditions at ultrasonic intensities within clinically safe limits (2 ). This platform represents a significant step toward precise, programmable drug delivery in anatomically constrained or delicate regions.[2025-0104]